SAN || Clinical News

Early psoriatic arthritis treatment with etanercept gives better outcomes

Posted on: 18/01/2015 - 18:54

Patients with psoriatic arthritis and psoriasis report having a better response to etanercept the earlier they are treated, according to a post hoc analysis of the PRESTA trial. Patients with...

Field of Interest: Rheumatology

Type: News Item

Efinaconazole topical solution effective against early onychomycosis

Posted on: 08/01/2015 - 18:17

Patients with early onychomycosis can be effectively treated with once-daily efinaconazole topical solution, 10%, according to data from more than 1,000 patients. “Early treatment before the...

Field of Interest: Dermatology

Type: News Item

Maintenance tacrolimus for eczema boosts quality of life

Posted on: 15/12/2014 - 14:13

AMSTERDAM – Twice-weekly proactive maintenance therapy with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis resulted in dramatic improvement in self-reported quality of...

Field of Interest: Dermatology

Type: News Item

Secukinumab tames psoriatic arthritis in FUTURE 2 trial

Posted on: 07/12/2014 - 19:50

BOSTON – Secukinumab improved quality of life and symptoms in patients with psoriatic arthritis, regardless of whether they had received prior anti-tumor-necrosis factor therapy or were concurrently...

Field of Interest: Rheumatology

Type: News Item

Few psoriatic arthritis patients achieve minimal disease activity on methotrexate

Posted on: 05/12/2014 - 16:16

BOSTON – It’s time to test whether methotrexate is really up to snuff as a first-line therapy for psoriatic arthritis, Canadian investigators say. They base that recommendation on findings from a...

Field of Interest: Rheumatology

Type: News Item

TNF-alpha blockers effective in sustaining reduced PsA activity

Posted on: 05/12/2014 - 16:02

A state of minimal disease activity in patients with psoriatic arthritis is sustainable over several years by using treatments with tumor necrosis factor–alpha blockers, according to findings from a...

Field of Interest: Rheumatology

Type: News Item

Novel oral prophylaxis tames hereditary angioedema

Posted on: 03/12/2014 - 18:13

AMSTERDAM – A targeted oral medication for the prevention of potentially life-threatening episodes of hereditary angioedema produced a clinically meaningful reduction in attack frequency in a...

Field of Interest: Dermatology

Type: News Item

Adapalene/benzoyl peroxide + doxycycline outscores oral isotretinoin

Posted on: 25/11/2014 - 16:01

AMSTERDAM – The combination of fixed-dose adapalene/benzoyl peroxide plus oral doxycyline is a reasonable alternative to oral isotretinoin in patients with severe nodular acne, according to the...

Field of Interest: Dermatology

Type: News Item

Dupilumab advances for severe atopic dermatitis

Posted on: 18/11/2014 - 19:45

AMSTERDAM – The novel biologic agent dupilumab showed strong dose-dependent efficacy in adults with moderate to severe atopic dermatitis not adequately controlled with topical medications in a...

Field of Interest: Dermatology

Type: News Item

Certolizumab achieves sustained skin improvement in psoriatic arthritis

Posted on: 17/11/2014 - 17:27

AMSTERDAM – Certolizumab pegol maintained significant improvement in dermatologic outcomes in psoriatic arthritis patients through 96 weeks of treatment in the phase III RAPID-PsA trial. Moreover,...

Field of Interest: Rheumatology

Type: News Item

« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters